219 related articles for article (PubMed ID: 9528858)
1. CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site.
Mancini DN; Rodenhiser DI; Ainsworth PJ; O'Malley FP; Singh SM; Xing W; Archer TK
Oncogene; 1998 Mar; 16(9):1161-9. PubMed ID: 9528858
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of CpG methylation in the BRCA1 promoter region.
DiNardo DN; Butcher DT; Robinson DP; Archer TK; Rodenhiser DI
Oncogene; 2001 Aug; 20(38):5331-40. PubMed ID: 11536045
[TBL] [Abstract][Full Text] [Related]
3. A CREB site in the BRCA1 proximal promoter acts as a constitutive transcriptional element.
Atlas E; Stramwasser M; Mueller CR
Oncogene; 2001 Oct; 20(48):7110-4. PubMed ID: 11704836
[TBL] [Abstract][Full Text] [Related]
4. Site-specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors.
Mancini DN; Singh SM; Archer TK; Rodenhiser DI
Oncogene; 1999 Jul; 18(28):4108-19. PubMed ID: 10435592
[TBL] [Abstract][Full Text] [Related]
5. High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors.
Wilcox CB; Baysal BE; Gallion HH; Strange MA; DeLoia JA
Cancer Genet Cytogenet; 2005 Jun; 159(2):114-22. PubMed ID: 15899382
[TBL] [Abstract][Full Text] [Related]
6. A methylation-dependent DNA-binding activity recognising the methylated promoter region of the mouse Xist gene.
Huntriss J; Lorenzi R; Purewal A; Monk M
Biochem Biophys Res Commun; 1997 Jun; 235(3):730-8. PubMed ID: 9207230
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
[TBL] [Abstract][Full Text] [Related]
8. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
9. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation.
Tang H; Goldberg E
J Androl; 2009; 30(2):157-67. PubMed ID: 18930904
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
Chan KY; Ozçelik H; Cheung AN; Ngan HY; Khoo US
Cancer Res; 2002 Jul; 62(14):4151-6. PubMed ID: 12124354
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells.
Rice JC; Massey-Brown KS; Futscher BW
Oncogene; 1998 Oct; 17(14):1807-12. PubMed ID: 9778046
[TBL] [Abstract][Full Text] [Related]
12. Methylation analysis of the promoter F of estrogen receptor alpha gene: effects on the level of transcription on human osteoblastic cells.
Penolazzi L; Lambertini E; Giordano S; Sollazzo V; Traina G; del Senno L; Piva R
J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):1-9. PubMed ID: 15261302
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region.
Magdinier F; Ribieras S; Lenoir GM; Frappart L; Dante R
Oncogene; 1998 Dec; 17(24):3169-76. PubMed ID: 9872332
[TBL] [Abstract][Full Text] [Related]
14. Single-site methylation within the p53 promoter region reduces gene expression in a reporter gene construct: possible in vivo relevance during tumorigenesis.
Pogribny IP; Pogribna M; Christman JK; James SJ
Cancer Res; 2000 Feb; 60(3):588-94. PubMed ID: 10676641
[TBL] [Abstract][Full Text] [Related]
15. Methylation of the BRCA1 gene in sporadic breast cancer.
Dobrovic A; Simpfendorfer D
Cancer Res; 1997 Aug; 57(16):3347-50. PubMed ID: 9269993
[TBL] [Abstract][Full Text] [Related]
16. Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers.
Archey WB; McEachern KA; Robson M; Offit K; Vaziri SA; Casey G; Borg A; Arrick BA
Oncogene; 2002 Oct; 21(46):7034-41. PubMed ID: 12370825
[TBL] [Abstract][Full Text] [Related]
17. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
18. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.
Chen ST; Lin SY; Yeh KT; Kuo SJ; Chan WL; Chu YP; Chang JG
Int J Mol Med; 2004 Oct; 14(4):577-82. PubMed ID: 15375584
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Epstein-Barr virus BamHI-H divergent promoter by DNA methylation.
Nonkwelo CB; Long WK
Virology; 1993 Nov; 197(1):205-15. PubMed ID: 8212555
[TBL] [Abstract][Full Text] [Related]
20. Isolation and initial characterization of the BRCA2 promoter.
Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
